image

Develop

Our funding programs support early stage, Ohio-based companies to achieve success.

Abeona Therapeutics

Abeona is developing novel gene therapies for children with rare genetic diseases. Our initial programs utilize technology exclusively licensed from Nationwide Children’s Hospital for the treatment of the deadly childhood genetic diseases Mucopolysaccharidosis (MPS) IIIA and IIIB. Also known as Sanfilippo Syndromes type A and type B, MPS III is a progressive neuromuscular disease with […]

view all clients

Global Cardiovascular Innovation Center